circRNA basic information
circBase ID: -
Name: hsa_circ_HIPK2
Synonym: circHIPK2
Host Gene: HIPK2
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005595
MONDO name: laryngeal squamous cell carcinoma
Disease details: laryngeal squamous cell carcinoma / LSCC
Disease DO ID:
2876
Disease MeSH ID:
-
Disease NCIt ID:
C4044
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

LSCC tissues; adjacent normal mucosa (ANM) tissues

Cell lines:

TU686; TU212; HNEpC; HEK293T

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: MCTS1, IL-6
Associated microRNA: miR-889-3p
Biological function: promotes proliferation and migration; promotes malignant progression
Molecular mechanism: Acts as a miRNA sponge for miR-889-3p, relieving repression of MCTS1 and promoting IL-6 secretion.
Biological pathway or process:

proliferation (promotes); migration (promotes); EMT (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; FISH / smFISH; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Western Blot; ELISA; In Vivo Animal Model; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis

Clinical significance:

High expression of circHIPK2 may predict the poor prognosis of LSCC; potential diagnostic and prognostic biomarker for LSCC.

Description:

circHIPK2 is up-regulated in LSCC tissues and cell lines and promotes proliferation and migration. It mainly localizes to the cytoplasm and functions as a ceRNA by sponging miR-889-3p, thereby increasing MCTS1 expression and enhancing IL-6 secretion to accelerate malignant progression, with potential diagnostic/prognostic value.

Confidence score:

0.8175

Other information
Title:

circHIPK2 promotes malignant progression of laryngeal squamous cell carcinoma through the miR-889-3p/MCTS1/IL-6 axis.

Journal: Translational oncology
Published: 2025
PubMed ID: 40222337
Study type:

combined biological and clinical study

Data availability: The data that has been used is confidential.; Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.tranon.2025.102390.
Code availability: -